[Federal Register Volume 67, Number 78 (Tuesday, April 23, 2002)]
[Notices]
[Pages 19759-19760]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-9843]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-02-43]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of Section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
CDC is requesting an emergency clearance from the Office of Management 
and Budget (OMB) to collect data under the Fertility Clinic Success 
Rate and Certification Act (FCSRCA) of 1992. Send comments to Anne 
O'Connor, CDC Assistant Reports Clearance Officer, 1600 Clifton

[[Page 19760]]

Road, MS D-24, Atlanta, GA 30333. Written comments should be received 
within 14 days of this notice. OMB is expected to act on the request of 
CDC within 21 days of publication of this notice.

Proposed Project

    Assisted Reproductive Technology (ART) Program Reporting System--
New--National Center for Chronic Disease Prevention and Health 
Promotion (NCCDPHP), Centers for Disease Control and Prevention (CDC).
    Background: Section 2(a) of Pub. L. 102-493 (known as the Fertility 
Clinic Success Rate and Certification Act of 1992 (FCSRCA), 42 U.S.C. 
263a-1(a)) requires that each assisted reproductive technology (ART) 
program shall annually report to the Secretary through the Centers for 
Disease Control and Prevention--(1) pregnancy success rates achieved by 
such ART program, and (2) the identity of each embryo laboratory used 
by such ART program and whether the laboratory is certified or has 
applied for such certification under this act.
    The Centers for Disease Control and Prevention (CDC) is seeking 
approval of a reporting system for Assisted Reproductive Technology 
(ART)Program from the Office of Management and Budget (OMB). This 
reporting system has been designed in collaboration with the Society 
for Reproductive Technology to comply with the requirements of the 
FCSRCA. The reporting system includes all ART cycles initiated by any 
of the approximately 400 ART programs in the United States, and covers 
the pregnancy outcome of each cycle, as well as a number of data items 
deemed important to explain variability in success rates across clinics 
and across individuals. Data is to be collected through computer 
software developed by SART in consultation with CDC.
    In developing the definition of pregnancy success rates and the 
list of data items to be reported, CDC has consulted with 
representatives of SART, the American Society for Reproductive 
Medicine, and RESOLVE, the National Infertility Association (a 
national, nonprofit consumer organization), as well as a variety of 
individuals with expertise and interest in this field. The average 
annual cost to the respondent, including data entry labor and fees, is 
estimated to be $2,140.

----------------------------------------------------------------------------------------------------------------
                                                                Number of     Average  burden/
               Respondents                    Number of        responses/       response (in      Total  burden
                                             respondents       respondent          hours)          (in hours)
----------------------------------------------------------------------------------------------------------------
ART Clinics.............................               400               220            \5/60\             7,333
                                         -------------------
----------------------------------------------------------------------------------------------------------------


    Dated: April 16, 2002.
Nancy E. Cheal,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 02-9843 Filed 4-22-02; 8:45 am]
BILLING CODE 4163-18-P